Mumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India’s pharmaceutical, nutraceutical, functional foods, and biopharmaceutical sectors, proudly celebrates over 44 years of innovation and service excellence. Founded in 1981 by visionary entrepreneur Gautam Shah, GCCPL has evolved into a globally connected and innovation-driven enterprise known for its commitment to trust, transparency, and quality.

What began as an API trading and distribution firm has transformed into a diversified pharmaceutical powerhouse. GCCPL’s impressive timeline of achievements includes:

• 2009/2010: Acquisition of Eagle Chemical Works, establishing its own API manufacturing capabilities
• 2009: Release of its first vaccine, marking a significant milestone in biopharmaceuticals
• 2010/2011: Launch of its P2P division, introducing affordable medicines to the Indian market
• 2018: Entry into the sports nutrition space
• 2022: Creation of a preventive healthcare division with a focus on gynecology and orthopedics
• 2023: Establishment of a dedicated vaccine division to expand immunization solutions

Driven by a mission to lead through innovative thinking and technology adoption, GCCPL delivers tailored solutions across pharmaceutical, nutraceutical, and functional food categories. The company continues to differentiate itself through its strong regulatory acumen, cutting-edge R&D, and a global network of manufacturing and distribution partners.

“At GCCPL, innovation is not a buzzword–it’s the foundation of our growth strategy,” said Founder and Chairman Gautam Shah. “We’re proud to be one of India’s few private companies to bring the pneumococcal vaccine to the domestic market, second only to Pfizer.”

Recent product highlights include UC-II®, a patented undenatured type II collagen supplement, and Pylopass™, a breakthrough strain-based probiotic–both showcasing GCCPL’s commitment to introducing clinically backed, innovative health solutions to India.

With a sterling reputation for regulatory compliance, deep market research, and financial integrity–as affirmed by CRISIL’s highest rating A2+ GCCPL stands as a trusted partner for businesses and healthcare providers seeking reliable, next-generation healthcare products.

About G.C Chemie Pharmie Pvt. Ltd.

Founded in 1981, GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global footprint. Known for its reliability, innovation, and commitment to quality, GCCPL offers customized, technology-driven healthcare solutions to meet the evolving needs of today’s market. The company maintains a strong presence in vaccines, preventive care, functional foods, and advanced supplements.

For queries –

Website: www.gccpl.com

New Delhi [India], June 2: At Manupatra, we have been at the forefront of technological innovation in the Indian legal landscape. Our continuous interactions with legal professionals and law students have given us first-hand feedback on the legal trends and technologies that have a direct impact on the Indian legal landscape.

Over the past couple of years, AI has permeated the daily lives of people, affecting both personal and professional spaces. In the legal arena, AI-powered tools have demonstrated clear benefits for legal professionals, from streamlining research, assisted drafting, and making case/ contract management easier. However, this has not been without incidents with lawyers and judges alike being found to have cited fabricated cases hallucinated by AI.

At Manupatra, we see the immense potential AI carries in being used for legal tasks. As such, we conducted a “first of its kind” nationwide survey to gauge the scale and state of artificial intelligence adoption across India’s legal landscape. This survey has captured firsthand insights from legal professionals and students to identify the critical gaps that must be addressed to ensure AI’s responsible, ethical, and effective deployment. Understanding these dynamics is essential, not only to inform policymakers and industry leaders but also to empower the legal community with best practices and risk mitigation strategies.

Manupatra is releasing its comprehensive “Adoption of AI in the Indian Legal Landscape” survey report. The survey gathered insights from 227 law students, advocates, in-house counsel, firm partners, academics, and judicial officers across India.

Key Findings:

• Digital-Native Demographic: 60% of respondents are aged 18-34, with law students (36.6%) and advocates (23.8%) leading participation, signaling strong grassroots readiness for AI experimentation.
• Widespread Early Adoption: Nearly 60% have used AI tools in the past year for legal research (77.9%), summarization (65.7%), and drafting support (54.7%).
• Productivity Gains vs. Trust Deficit: While 79.7% report significant time savings on repetitive tasks, only 4.1% fully trust AI outputs without human verification, and 48.8% insist on review before use.
• Critical Barriers: Over half (58.1%) cite unreliable output quality, 51.2% point to hallucinated or incorrect content, and 42.4% lament lack of India-specific legal context in existing tools.
• Governance Shortfalls: Although 77.1% believe firms should disclose AI use in advice and filings, just 11% have formal written AI policies in place.

Key Challenges Identified

• Unreliable Output Quality (58.14%): Over half of respondents flagged inconsistent accuracy and “hallucinated” content as top pain points when using AI tools.
• Data Privacy & Security (47.67%): Nearly half of users worry about protecting client information and complying with confidentiality obligations.
• Lack of India-Specific Legal Context (42.44%): AI models trained on global data often misinterpret or omit nuances of Indian statutes and precedents.
• Ethical & Professional Responsibility Concerns (38.37%): Professionals expressed unease about liability, bias, and the ethical use of AI in client work.
• Training Gaps & Awareness (40.12% & 34.30%): A significant portion cite limited staff training and low awareness of available tools as adoption barriers.

User Expectations & Future Outlook

• Mainstream Adoption Timeline: 35.68% expect AI to become a standard legal tool within 1-2 years, with only 3.96% believing it will take beyond five years.
• Positive Sentiment with Caution: While 46.25% hold a “mostly positive” view of AI’s impact and 18.06% see it as “transformative,” 45.37% adopt a balanced stance, recognizing both benefits and risks.
• Demand for Enablers: Respondents prioritize accredited training (67.40%), freemium or trial access to tools (66.52%), and formal policy guidance from bar councils or courts (47.58%) to bridge gaps and build trust.
• Co-pilot over Replacement: The prevailing expectation is that AI will augment the legal mind by streamlining research and drafting while final judgment will remain firmly human.

About Manupatra

Manupatra is the leading provider of legal, regulatory, business information and analytics that helps subscribers navigate the law faster and smarter. Manupatra is the first legal-tech company in India which pioneered online legal research in India since 2000. It is the largest and most comprehensive database of Indian & International legal materials, which provides search capabilities powered by AI and ML. A perfect blend of law and technology, Lawyers, law firms, judiciary, government, corporate legal departments, students trust Manupatra to provide them with comprehensive access to the law through an intuitive platform.

Lose Weight & Build Lean Muscle – The Best of Both Worlds

Mumbai, India – 27th May: GNC, a global leader in nutritional supplements, through Guardian Healthcare Pvt. Limited (“GNC India”), GNC’s master franchisee in India (https://guardian.in/), has announced the launch of GNC Pro Performance 100% Whey + Keto Surge, a revolutionary protein supplement that combines high-quality whey protein with fat-burning ingredients to support weight loss and lean muscle gain. For the first time in India, fitness enthusiasts can access a dual-action supplement that merges muscle-building and metabolism-boosting benefits in one powerful formula.

Ashutosh Taparia, Managing Director & Board Member of Guardian Healthcare Pvt. Limited, master franchisee of GNC in India stated,

“At GNC India, we continuously aim to introduce products that align with the evolving health goals of Indian consumers. As more people seek solutions that offer both fat loss and muscle gain, Keto Surge fills a critical gap. It’s not just a whey protein – it’s a step toward smarter, more effective fitness journeys.”

GNC 100% Whey + Keto Surge delivers 24g of premium-quality whey protein to support muscle recovery and growth. What sets it apart is its powerful fat metabolism blend — featuring ingredients like L-Carnitine, CLA, Garcinia Cambogia, and Digezyme. Together, these ingredients work to support appetite control, improve fat utilization as energy, and enhance digestion and nutrient absorption, making it an ideal choice for those pursuing fat loss without compromising muscle health.

Balaji Uppala, CEO of GNC India, added,

“With the rise of the GLP-1 movement, there’s a growing awareness and interest in science-backed weight loss solutions and Keto Surge is our answer to that. Keto Surge is a first-of-its-kind innovation tailored to Indian fitness enthusiasts who are looking to lose weight without compromising on muscle mass. It combines trusted protein quality with proven fat-burning ingredients.”

This formulation was developed indigenously by GNC India’s in-house R&D team in collaboration with medical experts, and reflects the brand’s growing focus on functional, multi-benefit supplements for the modern Indian lifestyle.

Designed for all fitness levels, from individuals aiming to tone up or manage weight as part of a healthier lifestyle, to seasoned athletes in a cutting phase, Keto Surge is the ideal supplement to support performance, fat metabolism, and overall body composition goals.

Now available in a delicious chocolate flavor, GNC 100% Whey + Keto Surge comes in convenient 1-pound, 2-pound, and 4-pound size variants, and is available for purchase on GNC India’s website, Amazon, Flipkart, Healthcare, Myntra, Hyugalife, and select offline stores.

Try India’s First Fat-Burning Whey – GNC 100% Whey + Keto Surge in super tasty chocolate flavor.Shop now and avail exclusive launch discounts & freebies.

 For media inquiries, please contact: 

Tanya Sharma, tanya.s@oneguardian.in

About GNC:

GNC is a leading global health and wellness brand that provides customers with a wide variety of science-based products and solution services to live well. The brand touches consumers worldwide by providing its products and services through company-owned retail locations, domestic and international franchise locations, digital commerce, and strong wholesale and retail partnerships across the globe. GNC’s diversified, multi-channel business model has worldwide reach and a well-recognized, trusted brand. By combining exceptional innovation, product development capabilities, and an extensive global distribution network, GNC manages a best-in-class product portfolio.

About Guardian Healthcare Private Limited:

Guardian Healthcare Private Limited, is the master franchisee holder of GNC for India. Guardian Healthcare, with 60+ premium pharmacies across India, serves over 10 million customers. Offering 100% reliable health, wellness, and pharmaceutical products, Guardian Pharmacy prioritizes reliability, customer satisfaction, and trust.